MO‐D‐ValB‐09: Residual Motion of Lung Tumors in End‐Of‐Inhale Respiratory Gating

R. I. Berbeco, S. Nishioka, H. Shirato, S. B. Jiang

Research output: Contribution to journalArticle

Abstract

Purpose: The intention of this study is to determine whether previously observed large external surrogate residual motion at end‐or‐inhale (EOI) translates into large tumor residual motion, and if improving the reproducibility at this phase can lessen the internal residual motion. Method and Materials: We simulate gated treatment at the EOI phase, using a set of recently measured internal/external correlated patient data. The 3D locations of internal fiducial markers placed near the target are tracked in real‐time with stereoscopic x‐ray fluoroscopy. An external surrogate respiratory gating system is synchronized with the fluoroscopic unit so that the log files contain the three‐dimensional marker position and the abdominal surface position at every time point. The internal and external measurements are taken even when the MV beam is gated off, throughout each treatment, so large amounts of internal/external‐correlated data were collected. Results: We found that under free‐breathing conditions the residual motion of the tumors is much larger for EOI phase than for end‐of‐exhale (EOE) phase. The mean value of residual motion at EOI was found to be 2.2 mm and 2.7 mm for amplitude and phase‐based gating, respectively; and, at EOE, 1.0 mm and 1.2 mm for the same quantities. However, the residual motion in the EOI gating window is correlated well with the reproducibility of the external surface position in the EOI phase. Using the results of a published breath‐coaching study, we deduce that the tumor residual motion at EOI would approach that at EOE under breath‐coaching conditions. Conclusion: We conclude that the same reproducibility of tumor location can be achieved at EOI as at EOE if breath coaching is implemented. Based on these results, we believe that inhale gating is preferable to exhale gating as long as proper margins are employed and breath coaching is performed.

Original languageEnglish (US)
Pages (from-to)2162-2163
Number of pages2
JournalMedical Physics
Volume33
Issue number6
DOIs
StatePublished - 2006

Fingerprint

Lung
Residual Neoplasm
Neoplasms
Fiducial Markers
Fluoroscopy
Respiratory System
X-Rays
Therapeutics
Mentoring

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

MO‐D‐ValB‐09 : Residual Motion of Lung Tumors in End‐Of‐Inhale Respiratory Gating. / Berbeco, R. I.; Nishioka, S.; Shirato, H.; Jiang, S. B.

In: Medical Physics, Vol. 33, No. 6, 2006, p. 2162-2163.

Research output: Contribution to journalArticle

Berbeco, R. I. ; Nishioka, S. ; Shirato, H. ; Jiang, S. B. / MO‐D‐ValB‐09 : Residual Motion of Lung Tumors in End‐Of‐Inhale Respiratory Gating. In: Medical Physics. 2006 ; Vol. 33, No. 6. pp. 2162-2163.
@article{282998c7830f4fa5990e5ac38142a24c,
title = "MO‐D‐ValB‐09: Residual Motion of Lung Tumors in End‐Of‐Inhale Respiratory Gating",
abstract = "Purpose: The intention of this study is to determine whether previously observed large external surrogate residual motion at end‐or‐inhale (EOI) translates into large tumor residual motion, and if improving the reproducibility at this phase can lessen the internal residual motion. Method and Materials: We simulate gated treatment at the EOI phase, using a set of recently measured internal/external correlated patient data. The 3D locations of internal fiducial markers placed near the target are tracked in real‐time with stereoscopic x‐ray fluoroscopy. An external surrogate respiratory gating system is synchronized with the fluoroscopic unit so that the log files contain the three‐dimensional marker position and the abdominal surface position at every time point. The internal and external measurements are taken even when the MV beam is gated off, throughout each treatment, so large amounts of internal/external‐correlated data were collected. Results: We found that under free‐breathing conditions the residual motion of the tumors is much larger for EOI phase than for end‐of‐exhale (EOE) phase. The mean value of residual motion at EOI was found to be 2.2 mm and 2.7 mm for amplitude and phase‐based gating, respectively; and, at EOE, 1.0 mm and 1.2 mm for the same quantities. However, the residual motion in the EOI gating window is correlated well with the reproducibility of the external surface position in the EOI phase. Using the results of a published breath‐coaching study, we deduce that the tumor residual motion at EOI would approach that at EOE under breath‐coaching conditions. Conclusion: We conclude that the same reproducibility of tumor location can be achieved at EOI as at EOE if breath coaching is implemented. Based on these results, we believe that inhale gating is preferable to exhale gating as long as proper margins are employed and breath coaching is performed.",
author = "Berbeco, {R. I.} and S. Nishioka and H. Shirato and Jiang, {S. B.}",
year = "2006",
doi = "10.1118/1.2241423",
language = "English (US)",
volume = "33",
pages = "2162--2163",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - MO‐D‐ValB‐09

T2 - Residual Motion of Lung Tumors in End‐Of‐Inhale Respiratory Gating

AU - Berbeco, R. I.

AU - Nishioka, S.

AU - Shirato, H.

AU - Jiang, S. B.

PY - 2006

Y1 - 2006

N2 - Purpose: The intention of this study is to determine whether previously observed large external surrogate residual motion at end‐or‐inhale (EOI) translates into large tumor residual motion, and if improving the reproducibility at this phase can lessen the internal residual motion. Method and Materials: We simulate gated treatment at the EOI phase, using a set of recently measured internal/external correlated patient data. The 3D locations of internal fiducial markers placed near the target are tracked in real‐time with stereoscopic x‐ray fluoroscopy. An external surrogate respiratory gating system is synchronized with the fluoroscopic unit so that the log files contain the three‐dimensional marker position and the abdominal surface position at every time point. The internal and external measurements are taken even when the MV beam is gated off, throughout each treatment, so large amounts of internal/external‐correlated data were collected. Results: We found that under free‐breathing conditions the residual motion of the tumors is much larger for EOI phase than for end‐of‐exhale (EOE) phase. The mean value of residual motion at EOI was found to be 2.2 mm and 2.7 mm for amplitude and phase‐based gating, respectively; and, at EOE, 1.0 mm and 1.2 mm for the same quantities. However, the residual motion in the EOI gating window is correlated well with the reproducibility of the external surface position in the EOI phase. Using the results of a published breath‐coaching study, we deduce that the tumor residual motion at EOI would approach that at EOE under breath‐coaching conditions. Conclusion: We conclude that the same reproducibility of tumor location can be achieved at EOI as at EOE if breath coaching is implemented. Based on these results, we believe that inhale gating is preferable to exhale gating as long as proper margins are employed and breath coaching is performed.

AB - Purpose: The intention of this study is to determine whether previously observed large external surrogate residual motion at end‐or‐inhale (EOI) translates into large tumor residual motion, and if improving the reproducibility at this phase can lessen the internal residual motion. Method and Materials: We simulate gated treatment at the EOI phase, using a set of recently measured internal/external correlated patient data. The 3D locations of internal fiducial markers placed near the target are tracked in real‐time with stereoscopic x‐ray fluoroscopy. An external surrogate respiratory gating system is synchronized with the fluoroscopic unit so that the log files contain the three‐dimensional marker position and the abdominal surface position at every time point. The internal and external measurements are taken even when the MV beam is gated off, throughout each treatment, so large amounts of internal/external‐correlated data were collected. Results: We found that under free‐breathing conditions the residual motion of the tumors is much larger for EOI phase than for end‐of‐exhale (EOE) phase. The mean value of residual motion at EOI was found to be 2.2 mm and 2.7 mm for amplitude and phase‐based gating, respectively; and, at EOE, 1.0 mm and 1.2 mm for the same quantities. However, the residual motion in the EOI gating window is correlated well with the reproducibility of the external surface position in the EOI phase. Using the results of a published breath‐coaching study, we deduce that the tumor residual motion at EOI would approach that at EOE under breath‐coaching conditions. Conclusion: We conclude that the same reproducibility of tumor location can be achieved at EOI as at EOE if breath coaching is implemented. Based on these results, we believe that inhale gating is preferable to exhale gating as long as proper margins are employed and breath coaching is performed.

UR - http://www.scopus.com/inward/record.url?scp=85024799315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024799315&partnerID=8YFLogxK

U2 - 10.1118/1.2241423

DO - 10.1118/1.2241423

M3 - Article

AN - SCOPUS:85024799315

VL - 33

SP - 2162

EP - 2163

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -